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Abstract
The transcription factors Emx2 and Pax6 are expressed in the proliferating zones of the developing rodent neocortex, and gradients
of expression interact in specifying caudal and rostral identities. Pax6 is also involved in corticoneurogenesis, being expressed by
radial glial progenitors that give rise to cells that also sequentially express Tbr2, NeuroD and Tbr1, genes temporally downstream of
Pax6. In this study, using in situ hybridization, we analysed the expression of EMX2, PAX6, TBR2, NEUROD and TBR1 mRNA in the
developing human cortex between 8 and 12 postconceptional weeks (PCW). EMX2 mRNA was expressed in the ventricular (VZ) and
subventricular zones (SVZ), but also in the cortical plate, unlike in the rodent. However, gradients of expression were similar to that of
the rodent at all ages studied. PAX6 mRNA expression was limited to the VZ and SVZ. At 8 PCW, PAX6 was highly expressed
rostrally but less so caudally, as has been seen in the rodent, however this gradient disappeared early in corticogenesis, by 9 PCW.
There was less restricted compartment-speciﬁc expression of TBR2, NEUROD and TBR1 mRNA than in the rodent, where the
gradients of expression were similar to that of PAX6 prior to 9 PCW. The gradient disappeared for TBR2 by 10 PCW, and for
NEUROD and TBR1 by 12 PCW. These data support recent reports that EMX2 but not PAX6 is more directly involved in arealization,
highlighting that analysis of human development allows better spatio-temporal resolution than studies in rodents.
Introduction
Cortical arealization controls the differentiation of the early embryonic
cortical primordium, a neuroepithelial sheet that lacks any apparent
regional-speciﬁc morphology or function, into the complex, regionally
diverse mature cerebral cortex. Although stimuli arising from
subcortical structures affect cortical differentiation, cortical-intrinsic
inﬂuences drive the early phases of arealization. The genes controlling
neocortical arealization are assumed to be expressed in graded
or restricted patterns in order to be able to specify regional identities
(Job & Tan, 2003; Mallamaci & Stoykova, 2006).
Two genes meeting these criteria in the rodent are Emx2 and Pax6
(O’Leary & Nakagawa, 2002). Pax6 encodes a protein containing a
paired domain and a homeodomain, and is mutated in patients with
aniridiaand inthemousemutantsmalleye,sey(Tonetal.,1991,1992),
while Emx2 is a homeobox-containing gene encoding a transcription
factor that is one homologue of the anterior-head-speciﬁc Drosophila
empty spiracles head gene (Simeone et al., 1992). In mice, both Pax6
and Emx2 expression are found in the telencephalon during neurogen-
esis (E10.5–18.5; Walther & Gruss, 1991; Simeone et al., 1992). In
Pax6 sey⁄sey mutant mice, studies of the expression of areal markers
such as Cad6, Cad8 and Id2, have indicated a reduction in size of
rostro-lateral areas and expansion of caudo-medial regions (Bishop
et al., 2000, 2002). In Emx2 null mice, a reduction in size of
caudal⁄medial cortical regions, together with an enlargement of those
with rostral⁄lateral identity (Bishop et al., 2000) is seen. Emx2 shows a
complementaryexpressionpatterntoPax6,andtheydownregulateeach
other in the cortex (Muzio et al., 2002). Pax6 also controls glutama-
tergicneuronalcellfateinrodents(Kroll&O’Leary,2005),andthatthe
expression pattern of the T-box domain containing transcription factor
Tbr2, a gene expressed by basal progenitors in the subventricular zone
(SVZ), exhibits a similar high rostro-lateral, low caudo-medial
expression pattern as that of Pax6 (Bulfone et al., 1999). Glutamatergic
projection neurons and their progenitors sequentially express Pax6
followed by Tbr2 during development. This sequence of expression is
followed by thebasic helix-loop-helix, pro-neural geneNeuroD andthe
Tbr2-related layer VI marker, Tbr1 (Hevner et al., 2006).
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European Journal of NeuroscienceIn the rodent, Emx2 and Pax6 are expressed in the ventricular zone
(VZ) of the dorsal telencephalon that gives rise to cortical neurons,
along two complementary tangential gradients. Although many
mechanisms involved in rodent cortical development are shared in
common with humans (Monuki & Walsh, 2001), the human cortex is
composed of different and more complex local area identities that
reﬂect differences in structure and function (Hill & Walsh, 2005).
These differences need to be considered when extending ﬁndings from
rodents to humans, and an important ﬁrst step is to analyse expression
patterns directly in humans. Therefore we analysed the temporal and
spatial mRNA expression patterns of EMX2 and PAX6, as well TBR2,
NEUROD and TBR1 from 8–12 postconceptional weeks (PCW). This
relates to an early period of cortical development before innervation of
thalamocortical ﬁbres (Kostovic & Rakic, 1990; Meyer et al., 2000).
Materials and methods
All reagents were purchased from VWR International (Lutterworth,
UK) unless otherwise stated.
Human tissue
Brains were dissected from human foetal and embryonic terminations
of pregnancies obtained from the MRC-Wellcome Trust Human
Developmental Biology Resource at Newcastle University (HDBR,
http://www.hdbr.org). Tissue from ages between 8 and 12 PCW (8
PCW, n = 5; 9 PCW, n = 3; 10–10.5 PCW, n = 3; 12–12.5 PCW,
n = 3) were used with maternal consent and approval of the local
University Hospital Ethical Review Committees. Age was estimated
from measurements of foot length and heel to knee length. These were
compared with a standard growth chart (Hern, 1984). Prior to
sectioning, brains were ﬁxed for 24 h at 4 C in phosphate-buffered
saline (PBS) containing 4% paraformaldehyde (PFA), and then
transferred to 70% ethanol for storage at 4 C. Samples were processed
and then embedded in parafﬁn. Eight-micron-thick sections were cut,
mounted on slides and used for in situ hybridization (ISH).
Probe manufacture
For PAX6 and EMX2, two sets of RNA probes were used yielding
similar results. One set of RNA probes was used for each of TBR1,
NEUROD and TBR2. In the case of PAX6 and EMX2, sense and
antisense probes were synthesized by transcribing linearized plas-
mid (pGEM3Z) containing 1200-bp (Emx2) and 720-bp (Pax6)
fragments [nucleotides 730–1930 of GenBank accession no.
NM_004098NM_004098 (Emx2) and nucleotides 416–1136 of Gen-
Bank accession no. BC011953 (Pax6)] with T7 or SP6 RNA
polymerases. Additionally, a DNA template for polymerase chain
reaction (PCR) was prepared for the production of the second set of
probes from a reverse transcription ﬁrst-strand synthesis reaction from
RNA that had already been extracted from a 5-mm slice dissected from
the caudal part of a human foetal cortex (9 PCW). PCR was carried out
using primers (MWG, Ebersberg, Germany) speciﬁc for either EMX2
or PAX6 ﬂanked by consensus sequences for T7 (anti-sense primer)
and SP6 (sense primer) RNA polymerases. Probes for TBR2,
NEUROD and TBR1 were also manufactured in a similar manner by
PCR from a cDNA template. The following primers were used (gene-
speciﬁc sequence underlined): EMX1 T7 AS: 5¢-TAA GTTAATACG
ACT CAC TAT AGG GCG AGT CAT TGG AGG TGA CAT CGA
TGT CC; EMX1 SP6 S: 5¢-AAT ACG ATT TAG GTG ACA CTA
TAG AAT ACC GCT GAC CGT GCA TCC GGC GCA C; EMX2
T7AS:5 ¢-TAA GTT AAT ACG ACT CAC TAT AGG GCG AGG
CTG AGG CTG TGT GCC AGC TGC; EMX2 SP6S: AATACG ATT
TAG GTG ACA CTA TAG AAT ACC AAG CGC TGC TTC ACC
ATC GAG TC; PAX6 T7AS: TAA GTT AAT ACG ACT CAC TAT
AGG GCG ATA GTG CAT GTT GTT CCA GGTT; PAX6 SP6S:
AATACG ATT TAG GTG ACA CTATAG AATACC TTC ACATCT
GGC TCC ATG TT; TBR1 T7AS:5 ¢-TAAGT TAA TAC GAC TCA
CTA TAG GGC GA CAC CAT CTG CCC ATT GTT ATT TGA;
TBR1 SP6S:5 ¢-AATACG ATT TAG GTG ACA CTATAG AATAC
TAC CAA GGA GCT CCG TTC TAC CAG; TBR2 T7AS:5 ¢-
TAAGT TAA TAC GAC TCA CTA TAG GGC GA CTA GTT TGT
TGG TCC CAG GTT GCT; TBR2 SP6S:5 ¢-AATACG ATT TAG
GTG ACA CTATAG AATAC AATACC AAC CCC GAC TGC ATA
TTG; NEUROD T7AS:5 ¢-TAAGT TAA TAC GAC TCA CTATAG
GGC GA ATC TCC GAC AGA GCC CAG ATG TAG; NEUROD
SP6S:5 ¢-AATACG ATT TAG GTG ACA CTA TAG AA TAC TGA
CCA AAT CGT ACA GCG AGA GTG. The particular gene-speciﬁc
regions were selected to ensure that standard PCR conditions could be
used as follows: 40 cycles of 95 C1 5s ,6 5  C for 30 s and 72 C for
45 s. The PCR product was electrophoresed on a 1.5% agarose gel,
and bands were cut out and puriﬁed with a gel extraction kit following
manufacturers’ instructions (Qiagen, Hilden, Germany). Puriﬁed
product was diluted in water (1 : 100) and used as a template in a
second round of PCR (with similar conditions). The PCR product was
subjected to electrophoresis through a 1.5% agarose gel, bands were
cut out and puriﬁed as before. Identity of the product was conﬁrmed by
sequencing. Seventy-ﬁve nanograms of puriﬁed PCR product or 1 lg
of linearized plasmid served as a template for the labelling reaction.
Digoxigenin (DIG)-labelled RNA probes were manufactured using a
DIG RNA labelling kit according to manufacturers’ instructions
(Roche, Lewes, UK). The labelled RNA was puriﬁed by centrifuging
through ProbeQuant G-50 micro columns (Amersham Biosciences,
Chalfont St Giles, UK). Labelling efﬁciency was determined with a dot
blot with control labelled RNA (DIG labelling kit; Roche).
ISH
ISH was carried out as previously described (Moorman et al., 2001),
with some modiﬁcations. Brieﬂy, slides were de-waxed in xylene,
gradually hydrated in decreasing ethanol concentrations before incu-
bation for 8 min in proteinase K (20 lg⁄mL) at room temperature.
Sections were ﬁxed for 20 min in 4% PFA⁄PBS, washed in PBS,
treated for 10 min in 0.1 m triethanolamine (Sigma-Aldrich, pH
8.0)⁄0.25% acetic anhydride⁄0.2% HCl, dehydrated in increasing
concentrations of ethanol and air-dried by ﬁltered air stream. Labelled
probe (300 ng) was used per 100 lL Dig Easy Hyb Mix (Roche).
Probe⁄Hyb Mix (200 lL) was used to cover each slide. Slides were
incubated in a hybridization chamber overnight at 68 C, washed in
50% formamide⁄2· standard sodium citrate (SSC) for 20 min at 65 C,
followed by four washes with decreasing SSC concentrations at 50 C
(2, 2· SSC washes and 2, 0.2· SSC washes, the ﬁnal at room
temperature). After brieﬂy washing in 0.1 m Tris (pH 7.6)⁄0.15 m
NaCl (Buffer 1), and blocking 10% foetal calf serum (FCS; Invitro-
gen)⁄Buffer1 for 1 h, sections were incubated with anti-DIG antibody
(Roche; diluted 1 : 1000 in 2% FCS⁄Buffer 1) at 4 C overnight. The
slides were washed in Buffer 1 for 6 · 30 min, and DIG antibody was
visualized with NBT⁄BCIP solution (Roche; 20 lL⁄mL) in 0.1 m Tris
(pH 9.5)⁄0.1 m NaCl (Buffer 2). Developing was stopped by rinsing
slides in Buffer 2 then distilled H2O followed by 1%HCl⁄methanol and
dH2O. Sections were mounted using Aquamount. Comparison of
staining between sense and anti-sense probes was carried out to ensure
speciﬁcity (see Supporting information, Fig. S1).
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Parafﬁn sections were de-waxed in two changes of xylene and
re-hydrated in decreasing concentrations of ethanol in water. Sections
were then treated with 3% hydrogen peroxidase (Sigma-Aldrich) for
10 min, and boiled in 10 mm citrate buffer before incubation with
primary antibody [Pax6: diluted 1 : 300; Covance, Princeton NJ,
USA; Emx2: 1 : 200; Sigma-Aldrich; in 0.3% PBS with 0.3% Triton
X-100 (PBS-T) and 3% horse serum; Vector Laboratories, Peterbor-
ough, England]. Sections were incubated in a moist chamber at 4 C
overnight, washed in PBS-T and incubated with a corresponding
biotinylated secondary antibody (Vector Laboratories; 1 : 300 in PBS-
T) at 4 C for 2 h. After a further PBS-T wash, slides were incubated
for 1 h with streptavidin-horseradish peroxidase (Vector Laboratories;
1 : 200 in PBS-T). Antibody–epitope interactions were visualized
with 0.05% diaminobenzidine⁄0.003% hydrogen peroxidase in PBS
(Sigma-Aldrich) for 10–20 min. Sections were then dehydrated in
increasing ethanol concentrations, cleared in xylene and mounted
using histamount (Vector Laboratories).
Results
The localization and gradient expression patterns of EMX2 and PAX6
mRNA were analysed by nonradioactive ISH (sense controls are
shown in supporting Fig. S1). Furthermore, the localization and
gradients of TBR2, NEUROD and TBR1, genes downstream of PAX6,
which are thought to be important in the neurogenesis of cortical
projection neurons, were also examined.
Laminar expression of EMX2 and PAX6 during early human
cortical development
At 8 PCW, tissue ISH revealed expression of EMX2 and PAX6 in the
VZ and SVZ of the dorsal forebrain (Fig. 1A and B); however, by 9
PCW, expression of EMX2 was also observed in the newly forming
cortical plate (CP; Fig. 1C), where EMX1 was also found to be
expressed (in supporting Fig. S2), while PAX6 remained in the
proliferative layers (Fig. 1D). From 10 PCW, EMX2 expression had
switched to be predominantly within the CP, although lower levels
were detected within the VZ⁄SVZ (Fig. 1E). By 12 PCW intense
staining for EMX2 mRNA was evident in the CP, particularly in the
newly-forming outer layers, while showing a restricted pattern of
distribution in the VZ (Fig. 1G). It is worth noting that EMX2
protein was generally found to localize in the same locations as the
EMX2 RNA (in supporting Fig. S3). PAX6 RNA and protein
expression was limited to the proliferative zones throughout all stages
analysed (Fig. 1D,F and H; in supporting Fig. S3). Thus, EMX2
showed clear differences in its expression between human (where it is
detected in both the proliferating zones and in the CP) and mouse
(where it is detected primarily in proliferating zones). In contrast,
PAX6 expression follows a more similar pattern to that seen in
rodents throughout development, being mainly localized to the
proliferative layers.
EMX2 and PAX6 gradients in the developing human cortex
In rodents, Pax6 and Emx2 exhibit reciprocal and opposing caudal-
rostral medial-lateral gradients that are instrumental in setting up
cortical maps that control the expression of areal markers (Bishop
et al., 2000). Here we show that at 8 PCW both genes display similar
gradients of expression in human (Fig. 2A,B,E and F).
At 8 PCW ISH for PAX6 mRNA revealed a high rostral and lateral
expression of the gene, with low caudal and medial expression
(Fig. 2B and F). Conversely, EMX2 showed a high caudo-medial to
low rostro-lateral gradient in expression (Fig. 2A and E). The
observed gradient of PAX6 had disappeared by 9 PCW (Fig. 2D and
H), although the EMX2 gradient was maintained at 9 weeks (Fig. 2C
and G) and at all other stages analysed (data not shown), even
though EMX2-expressing cells had predominately translocated to the
CP.
Fig. 1. Laminar localization of EMX2 and PAX6 during early foetal
development of the human neocortex. ISH revealed a changing laminar
distribution of EMX2 mRNA between 8 and 12 postconceptional weeks
(PCW). Expression was observed only in the subventricular and ventricular
zones (SVZ ⁄ VZ) at 8 PCW (A). However, by 9 PCW expression was also
noted in the cortical plate (CP) (C). Subsequently, expression of EMX2
intensiﬁed in the CP at 10 PCW (E) and 12 PCW (G), while still present in
the SVZ and VZ at lower intensities. At 12 PCW, the highest level of EMX2
mRNA expression was found in the CP most proximal to the marginal zone
(MZ). PAX6 was observed predominantly in the proliferative zones (SVZ ⁄ VZ)
of the developing cortex (B, D, F, H). PAX6 mRNA was observed most
intensely at 8 PCW in the VZ (A), after which a decrease was observed at 9
PCW (C). Staining intensity of PAX6 decreased at 10 PCW and 12 PCW (F
and H, respectively) due to the decrease in the relative thickness of the VZ.
Sections for EMX2 and PAX6 are taken from the caudal and rostral poles
respectively. Scale bars: 100 lm (A, C); 200 lm (E, G). IZ, intermediate
zone; SP, subplate.
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early human cortical development
Tbr2, NeuroD and Tbr1 exhibit distinct compartmental-speciﬁc
localizations in rodents (Hevner et al., 2006). Here we have examined
whether similar localizations are observed during the development of
the human cortex between 8 and 12 PCW. At 8 PCW, TBR2 RNAwas
located within a distinct layer between the VZ and the CP, probably
corresponding to a newly formed SVZ. In a similar fashion, NEUROD
was also found to be present in a discrete layer above the VZ, while
TBR1 exhibited a more widespread expression pattern including the
SVZ and CP (Fig. 3A–C). It was interesting to note that NEUROD was
expressed in the CP at 8 PCW in more lateral locations (see Fig. 4E).
By 9 PCW, TBR2 expression was predominantly limited to the SVZ,
while both NEUROD and TBR1 exhibited expression additionally in
theCP,wheremostoftheexpressionofTBR1wasobserved(Fig.3D–F).
These expression patterns were maintained for all three genes at 10
PCW (Fig. 3G–I). As the SVZ had expanded by 12 PCW, the majority
of TBR2 expression remained at the border of the SVZ and VZ, with
less intense staining throughout the SVZ but most intense within the
inner SVZ(Fig. 3J).NEUROD and TBR1were both mainly localized to
the CP; however, both were expressed at the border of the SVZ and VZ
and throughout the SVZ at lower levels (Fig. 3K and L). Taken together
with the laminar localization of PAX6, these data show that although
TBR2, NEUROD and TBR1 exhibit some degree of compartmental-
speciﬁc expression, together with PAX6, all four were expressed within
the SVZ during early human corticogenesis, unlike in rodents where
Tbr1 is absent (Hevner et al., 2006).
TBR2, NEUROD and TBR1 gradients in the developing
human cortex
Tbr2, NeuroD and Tbr1 are sequentially expressed temporally
downstream of Pax6 by progenitor cells undergoing differentiation
and radial migration before ﬁnally residing in the CP as cortical
glutamatergic projection neurons (Hevner et al., 2006). Previous
studies in rodents indicate that Tbr2 is expressed in a high rostral-
lateral, low caudal-medial gradient similar to Pax6 (Bulfone et al.,
1999). At 8 PCW, TBR2 mRNA, as well as NEUROD, and TBR1
exhibited a gradient similar to PAX6 (Fig. 4A–C, D–F). However, at 9
PCW, when the PAX6 gradient has disappeared, the high rostral-
lateral, low caudal-medial gradients of the other three transcription
factors were maintained, although the TBR2 gradient was less
pronounced (Fig. 4G–I, J–L), and by 10 PCW it had deﬁnitely
disappeared, and gradients for NEUROD and TBR1 were barely
discernible (Fig. 4M–O). By 12 PCW all gradients were absent (data
not shown). Therefore the sequential loss of gradients of these
transcription factors broadly mirrors the sequence in which these
transcription factors are ﬁrst expressed: PAX6 at 9 PCW; TBR2 at 10
PCW; and NEUROD and TBR1 at 12 PCW.
Discussion
In order to examine the relative roles of PAX6 and EMX2 during
arealization, we have examined the expression patterns of these two
transcription factors using ISH during the early stages of corticoge-
nesis in human. As we initially observed that the PAX6 gradient
disappeared early in corticogenesis, we also analysed the laminar
localization and gradients of expression of TBR2, NEUROD and
TBR1, genes temporally downstream of PAX6 and expressed by cells
during neurogenesis, in order to determine how they compare with
PAX6 (all gene expression patterns summarized in Fig. 5).
Laminar localization of Emx2 and Pax6
Previous work in our laboratory has demonstrated the presence of
EMX2 mRNA in the proliferative zone of the developing human
forebrain, at relatively low levels, from Carnegie stage 18 (CS18;
44 days; 6.5 PCW) until CS21 (52 days; 7.5 PCW; Lindsay et al.,
2005; Sarma et al., 2005), when the CP starts to emerge (Meyer et al.,
2000). Here we report the expression of EMX2 during the early stages
of CP formation, where the functions of this gene are thought to be
critical in modulating arealization mechanisms (Cecchi & Boncinelli,
2000). A principal ﬁnding of this study is that EMX2 mRNA
Fig. 2. EMX2 and PAX6 gradients in the developing human cortex. ISH
analysis of sagittal sections at 8 postconceptional weeks (PCW; A, B) revealed
that EMX2 and PAX6 mRNA were expressed in reciprocal rostro-caudal
gradients. While EMX2 was expressed high caudally and low rostrally, PAX6
showed an opposite gradient of expression. In sagittal sections at 9 PCW (C, D),
EMX2mRNAmaintainedasimilarcaudal-rostral gradientto thatseenat 8PCW.
The previously observed PAX6 expression gradient, however, disappeared.
Similarly, in horizontal sections at 8 PCW, EMX2 and PAX6 exhibited reciprocal
opposing medial-lateral gradients (E, F). EMX2 expression was observed high
medially and low laterally with the opposite for PAX6. While the EMX2 gradient
still persisted at 9 PCW (G), the PAX6 medial-gradient disappeared (H). Scale
bars: 500 lm. Ca, caudal; Lt, lateral; Md, medial; Ro, rostral.
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in rodents. In the rodent, Emx2 mRNA localized chieﬂy to the
VZ⁄SVZ (Cecchi, 2002), whereas in the human, expression of EMX2
was present in the VZ⁄SVZ only during the early stages of CP
formation; however, from 10 PCW onwards expression had switched
predominantly to the CP. Emx2 has been reported to be expressed at
low levels in the rodent CP, but only in the apical dendrites of CP
neurons synapsing with the Cajal–Retzius cells of the marginal zone.
In rodents, expression of Emx1, a transcription factor that is related to
Emx2, is found to be expressed within the CP, but is not thought to be
involved in mechanisms regulating cortical arealization (Gulisano
et al., 1996). However, double mutants indicate that Emx1 co-operates
with Emx2 to regulate cortical size, lamination, neuronal differenti-
ation, development of cortical efferents and thalamocortical path
ﬁnding (Bishop et al., 2003). Our observations that EMX2 expression
in the CP is reminiscent of that of Emx1 in rodents lead to the
intriguing possibility that EMX1 in humans may take over EMX2
function in cortical arealization in humans. However, the majority of
EMX1 expression is also found in the CP (in supporting Fig. S2) and
this is consistent with previous reports in rodents.
We have previously demonstrated the early expression of the PAX6
gene during human development, speciﬁcally within the dorsal
forebrain at 6.5–7 PCW (Kerwin et al., 2004; Lindsay et al., 2005)
by ISH, and from 8 to 12 PCW during early cortical development by
immunohistochemistry (Bayatti et al., 2008). We have extended these
observations by analysing the extent and localization of PAX6 mRNA
expression during early human neocortical development. Unlike
EMX2, the general laminar expression of PAX6 in humans resembled
that described in the rodent, being conﬁned to the proliferative zones
at all ages studied. The observation that PAX6 and EMX2 laminar-
speciﬁc expression diverged as early as 9 PCW implies differing roles
for these transcription factors during cortical development, whilst
EMX2 and PAX6 may be important in regulating processes leading to
the initial formation of the CP (at⁄or before 8 PCW; Gotz & Huttner,
2005). Additionally, PAX6 expressed in the human SVZ has been
implicated in controlling the neurogenesis of c-aminobutyric acid
(GABA)ergic and glutamatergic neurons (Letinic et al., 2002; Mo &
Zecevic, 2008). Recently, analysis of a transgenic mouse model that
carries several copies of the human PAX6 locus, expressing up to three
times more protein than the wild-type, provided evidence that PAX6
may not be directly involved in arealization. These mice exhibited no
changes in Emx2 protein localization, and expression of the areal
markers Id2 and Ephrin-B2 were also unaffected. However, reductions
were seen in thickness of cortical layers, probably due to a reduced
rate of proliferation in overexpressing cells (Manuel et al., 2007).
A study identifying genes regulated by Emx2 in neuronal precursors
in vitro has identiﬁed a gene proﬁle that would be consistent with
conferring maturation, i.e. differentiation of early precursors and⁄or
induction of a migratory speciﬁcation to these normally resident cells
(Gangemi et al., 2006). Given its expression gradient and location
Fig. 3. Laminar localization of TBR2, NEUROD and TBR1 mRNA during
early foetal development of the human neocortex. ISH analysis of TBR2,
NEUROD and TBR1 mRNA in the developing human cortex between 8 and 12
postconceptional weeks (PCW). At 8 PCW, TBR2 and NEUROD exhibit
restricted expression in what is probably the subventricular zone (SVZ) of
the developing cortex (A, B), while TBR1 expression additionally includes the
cortical plate (CP; C). By 9 PCW, the SVZ is more distinctly identiﬁed at
the border with the ventricular zone (VZ). All three genes are absent from the
majority VZ but possibly present at the SVZ border, TBR2 being restricted to
the SVZ (D) while NEUROD and TBR1 are additionallypresent in the CP (E, F).
The expression patterns of these genes are similar at 10 PCW (G–I); however,
TBR2 exhibits a more restricted expression close to the SVZ ⁄ VZ border. By 12
PCW (J–L), all three show high expression in the ISVZ, while NEUROD and
TBR1 show more widespread expression in the SVZ and CP. Scale bars: 100 lm
(C, F); 200 lm (I, L). ISVZ, inner SVZ; IZ, intermediate zone; MZ, marginal
zone; OSVZ, outer SVZ; SP, subplate.
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stages of arealization and may control expression of areal markers
directly. Recently, a study using nestin-Emx2 transgenic mice observed
rostro-lateral shifts in the primary sensory and motor areas (Hamasaki
et al., 2004). As these mice do not show defects in thalamocortical
pathﬁnding, regional-speciﬁc loss in cortical tissue or differences in
Fgf8 expression, which previously obscured interpretation of the
function of Emx2 in Emx2 null mice, the authors concluded that Emx2
is directly involved in the mapping of primary cortical areas. Whilst our
ﬁndings support these conclusions, we propose that in humans, due to
its extended presence, EMX2 acts predominantly in the CP, in contrast
to rodents where Emx2 in progenitors in the VZ is thought to impart
positional identity to neuronal progeny.
EMX2 and PAX6 gradients during early human cortical
development
It has been proposed that Emx2 and Pax6 are two key regulatory genes
that control neocortical arealization through expression in graded,
restricted patterns in the embryonic cortex (O’Leary & Nakagawa,
2002; Job & Tan, 2003). This study demonstrates that in the
developing human neocortex, EMX2 and PAX6 are expressed in
counter caudomedial⁄rostrolateral gradients, in a similar manner to
that observed in rodents. However, this pattern of expression is
restricted to the period of development up to 9 PCW. Following this,
EMX2 maintains a gradient whereas PAX6 becomes uniformly
expressed throughout the proliferating zones of the cortex (Fig. 3D
and H, respectively). If EMX2 and PAX6 play a role in cortical
arealization in human development they are only able to interact up to
the time the CP is initially formed and very soon thereafter.
PAX6 may therefore affect arealization indirectly. The ﬁrst cells to
populate the CP form layer VI and contribute cells to the subplate
(Kostovic & Rakic, 1990). These cells are crucial in guiding thalamic
afferents to different regions of the cortex, as they send out axons to
the thalamus that meet incoming thalamic axons, providing guidance
cues (Molnar & Blakemore, 1995; Hevner et al., 2002). The regional
identities of primary areas of the cortex are inﬂuenced by the thalamic
innervation they eventually receive. Pax6 mutant mice exhibit defects
in this thalamic innervation as well as in reciprocal cortical pathﬁnding
(Hevner et al., 2002), as axons do not reach their targets suggesting
that Pax6 is important in the cortex for such events. As the ﬁrst CP
cells do not express Pax6, Pax6-dependent processes such as
pathﬁnding may be mediated by other transcription factors such as
Tbr1 and NeuroD that are expressed in differing compartments
downstream of Pax6 during the process of progenitor migration and
differentiation (Hevner et al., 2006).
Localization and gradients of PAX6, TBR2, NEUROD
and TBR1
Although PAX6 mRNA does not exhibit a gradient of expression from
9 PCW onwards in humans, it is possible that downstream transcrip-
tion factors may be responsible for further arealization mechanisms in
Fig. 4. TBR2, NEUROD, and TBR1 gradients in the developing human cortex.
Expression analysis of TBR2, NEUROD and TBR1 transcription factors
temporally downstream of PAX6 during neurogenesis demonstrates similar
gradients of expression. At 8 postconceptional weeks (PCW), all three genes
exhibited high rostral-low caudal (A–C), high lateral-low medial (D–F)
expression. These gradients persisted at 9 PCW (G–I and J–L, respectively);
however, the TBR2 gradient was not as pronounced (G and J). By 10 PCW the
TBR2 gradient was absent (M and P), the NEUROD and TBR1 gradients were
becoming less pronounced (N, O, Q and R). By 12 PCW, there were no
gradients of expression of any of these three transcription factors (data not
shown). Higher magniﬁcation images of respective boxed areas are indicated
by single and double asterisks. Sections shown are in the sagittal plane (A–C,
G–I and M–O), horizontal plane (D–F) or coronal plane (J–L and P–R). Scale
bars: 200 lm. Ca, caudal; Lt, lateral; Md, medial; Ro, rostral.
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compartmental localization of TBR2 and TBR1 mRNA is consistent
withpreviousstudiesoftheproteinexpression(Bayattietal.,2007).Our
results further indicate that in addition to TBR2, NEUROD and TBR1
form gradients similar to that of PAX6 in compartments through which
progenitors and subsequent immature neurons migrate during cortical
development (summarized inFig. 5).TBR2 forms a gradient inthe SVZ
from 8 to 10 PCW, whilst NEUROD and TBR1 also exhibit gradients in
thiscompartment.InterestinglythesegradientsarealsopresentintheCP
forTBR1andNEURODfrom8and9PCW,respectively,untilatleast10
PCW. During this period TBR1, which is expressed by ‘early-born’
neurons including SP neurons and those in layer VI (Bulfone et al.,
1995;Hevneretal.,2003),isexpressedthroughouttheCP.Ourprevious
observations show that the layer V marker Er81 appears later than 12
PCW in the human cortex (Bayatti et al., 2007). All four of these
transcription factors are localized within the SVZ, suggesting that
PAX6–TBR2–NEUROD–TBR1 transitions all occur within this com-
partment. Considering the relative size and degree of differentiation of
the human SVZ during development compared with that of the rodent,
this observation supports a fundamental role for this compartment
during corticogenesis. This study has highlighted that the location of
TBR2 is a particularly good marker for the SVZ at early stages. In
particular it predominantly localizes to the inner subventricular zone
(ISVZ)characterizedinthemacaqueatE46,beforethedifferentiationof
theSVZandappearanceofanoutersubventricularzone(OSVZ)(Smart
etal.,2002).ThemajorityofTBR2expressionismaintainedintheISVZ
atlaterstagesandcorrespondstothejunctionbetweentheISVZandVZ.
Future experiments should characterize whether the SVZ contributes to
arealization mechanisms, and if EMX2 and these transcription factors
are expressed within the same cells during their migration and
development. In addition, putative interactions between these transcrip-
tion factors and EMX2 should be analysed, in a similar manner to that
whichPAX6andEMX2regulateeachotherintheVZofrodents(Muzio
et al., 2002).
In conclusion, during human neocortical development, EMX2 and
PAX6 expression patterns diverge at an early stage, when in rodents
they are still presumed to be regulating the initial phases of
arealization by reciprocal gradients of expression. However, TBR2,
NEUROD and TBR1, temporally downstream genes of PAX6, maintain
early PAX6-like gradients until 12 PCW in different compartments of
the developing cortex (summarized in Fig. 5). The extended period of
gestation in humans, as compared with that in rodents, enables ﬁner
spatiotemporal resolution of overlapping gene expression patterns.
The majority of neurogenesis in the human forebrain occurs between 8
and 16 PCW (ten Donkelaar, 2000), in comparison to rodents in which
similar events occurs within days. All the transcription factors
described in this study are likely to possess additional functions
during this extended period of human cortical development. Further
analysis of the actions of these genes in humans using in vitro models
may shed light on their functions during human development.
Supporting information
Additional Supporting Information may be found in the online version
of this article:
Fig. S1. Detection of anti sense and sense probes for EMX1, EMX2,
PAX6, TBR2, NEUROD and TBR1.
Fig. S2. Laminar EMX1 expression in the early human fetal cortex.
Fig. S3. Laminar localisation of EMX2 and PAX6 protein during early
fetal development of the human neocortex.
Fig. 5. Summary of changes in expression patterns of EMX2, PAX6, TBR2, NEUROD and TBR1 during early development of the human cerebral cortex. At 8
postconceptional weeks (PCW) EMX2 and PAX6 are localized within the proliferative zones of the developing cortex in opposing rostro-lateral ⁄ caudo-medial
gradients. From 9 to 12 PCW onwards the majority of EMX2 expression is found in the cortical plate (CP), where a similar gradient exists to that observed in the
subventricular zone (SVZ) ⁄ ventricular zone (VZ). By this time the PAX6 gradient has disappeared and expression is widespread throughout the SVZ ⁄ VZ only.
However, the mRNA of transcription factors downstream of PAX6 in neurogenesis form PAX6-like gradients in different compartments during this time period.
TBR2 exhibits a PAX6-like gradient within the SVZ until 10 PCW. NEUROD, which initially is not expressed in the CP, also forms a gradient within the SVZ at 8
PCW, which extends to the SP ⁄ intermediate zone (IZ) and CP at 9 PCW. The TBR1 gradient is also observed from 8 PCW and encompasses all compartments
outside of the VZ, most prominently within the CP, but disappears before 12 PCW. Thus, as EMX2-expressing cells migrate from the VZ to the CP, they pass through
compartments expressing genes downstream of PAX6 that exhibit PAX6-like gradients.
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